# Metabolic Mapping to Measure Retinal Metabolism

> **NCT00385333** · PHASE2 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 28 (actual)

## Conditions studied

- Macular Degeneration
- Diabetic Retinopathy
- Hippel-Landau Disease
- Mitochondria

## Interventions

- **PROCEDURE:** Feasibility Study - Imaging System

## Key facts

- **NCT ID:** NCT00385333
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09-29
- **Primary completion:** 2008-06-01
- **Final completion:** 2010-09-16
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00385333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00385333, "Metabolic Mapping to Measure Retinal Metabolism". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00385333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*